Dimitrios Tsiantoulas
Overview
Explore the profile of Dimitrios Tsiantoulas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1325
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Eslami M, Meinl E, Eibel H, Willen L, Donze O, Distl O, et al.
Front Cell Dev Biol
. 2020 Nov;
8:577662.
PMID: 33240880
B cell activation factor of the TNF family (BAFF/BLyS), an essential B cell survival factor of which circulating levels are elevated in several autoimmune disorders, is targeted in the clinic...
12.
Nus M, Basatemur G, Galan M, Cros-Brunso L, Zhao T, Masters L, et al.
Arterioscler Thromb Vasc Biol
. 2020 Sep;
40(11):2598-2604.
PMID: 32907369
Objective: NR4A orphan receptors have been well studied in vascular and myeloid cells where they play important roles in the regulation of inflammation in atherosclerosis. NR4A1 (nerve growth factor IB)...
13.
14.
Clement M, Raffort J, Lareyre F, Tsiantoulas D, Newland S, Lu Y, et al.
Circ Res
. 2019 Oct;
125(11):1019-1034.
PMID: 31610723
Rationale: Atherosclerosis is a chronic inflammatory disease. Recent studies have shown that dysfunctional autophagy in endothelial cells, smooth muscle cells, and macrophages, plays a detrimental role during atherogenesis, leading to...
15.
Kiss M, Ozsvar-Kozma M, Porsch F, Goderle L, Papac-Milicevic N, Bartolini-Gritti B, et al.
Front Immunol
. 2019 Jul;
10:1607.
PMID: 31354740
Complement factor H (CFH) has a pivotal role in regulating alternative complement activation through its ability to inhibit the cleavage of the central complement component C3, which links innate and...
16.
Tsiantoulas D, Mallat Z
Cardiovasc Res
. 2019 Jun;
115(13):1813-1814.
PMID: 31179492
No abstract available.
17.
Bagchi-Chakraborty J, Francis A, Bray T, Masters L, Tsiantoulas D, Nus M, et al.
Arterioscler Thromb Vasc Biol
. 2019 May;
39(7):1379-1389.
PMID: 31092015
Objective- Investigate the impact of modulating B cell FcγRIIb (Fcγ receptor IIb) expression on atherosclerosis. Approach and Results- Western diet-induced atherosclerosis was assessed in Ldlr or Apoe mice with B...
18.
Sage A, Tsiantoulas D, Binder C, Mallat Z
Nat Rev Cardiol
. 2018 Nov;
16(3):180-196.
PMID: 30410107
The cardiovascular system is subject to hyperlipidaemic, inflammatory, and pro-oxidant stressors. Over time, these factors drive prevalent chronic diseases, of which atherosclerosis is most prominent and accounts for the majority...
19.
Tsiantoulas D, Sage A, Goderle L, Ozsvar-Kozma M, Murphy D, Porsch F, et al.
Circulation
. 2018 Jun;
138(20):2263-2273.
PMID: 29858401
Background: Atherosclerotic cardiovascular disease (heart attacks and strokes) is the major cause of death globally and is caused by the buildup of a plaque in the arterial wall. Genomic data...
20.
Nus M, Tsiantoulas D, Mallat Z
Eur J Pharmacol
. 2017 Sep;
816:76-81.
PMID: 28882560
Atherosclerosis is a leading cause of death worldwide. It is a complex chronic inflammatory disease involving interactions between vascular, circulating and immune cells. B cells play an important role in...